Y-box binding protein 1 enhances DNA topoisomerase 1 activity and sensitivity to camptothecin via direct interaction.
about
Mitochondrial Transcription Factor A and Mitochondrial Genome as Molecular Targets for Cisplatin-Based Cancer ChemotherapyCamptothecin (CPT) and its derivatives are known to target topoisomerase I (Top1) as their mechanism of action: did we miss something in CPT analogue molecular targets for treating human disease such as cancer?
P2860
Y-box binding protein 1 enhances DNA topoisomerase 1 activity and sensitivity to camptothecin via direct interaction.
description
2014 nî lūn-bûn
@nan
2014 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Y-box binding protein 1 enhanc ...... thecin via direct interaction.
@ast
Y-box binding protein 1 enhanc ...... thecin via direct interaction.
@en
type
label
Y-box binding protein 1 enhanc ...... thecin via direct interaction.
@ast
Y-box binding protein 1 enhanc ...... thecin via direct interaction.
@en
prefLabel
Y-box binding protein 1 enhanc ...... thecin via direct interaction.
@ast
Y-box binding protein 1 enhanc ...... thecin via direct interaction.
@en
P2093
P2860
P1476
Y-box binding protein 1 enhanc ...... thecin via direct interaction.
@en
P2093
Hidetaka Uramoto
Hiroto Izumi
Ke-yong Wang
Ken-ichi Ito
Kimitoshi Kohno
Yoshifumi Nakayama
Yun-peng Liu
P2860
P356
10.1186/PREACCEPT-3309941251415325
P577
2014-12-24T00:00:00Z